Related Experiment Videos
Emphysema-induced reductions in locomotory skeletal muscle contractile function
John P Mattson1, James C Martin
1Department of Health and Excercise Science, Adolphus College, 212C Lund Center, 800 West College Avenue, Gustavus Adolphus College, St. Peter, MN 56082, USA. jmattson@gac.edu
Experimental Physiology
|March 10, 2005
Summary
Emphysema, a condition linked to COPD, significantly increases skeletal muscle fatigability and slows recovery. This dysfunction in locomotory muscles may contribute to exercise intolerance in COPD patients.
Area of Science:
- Pulmonary Medicine
- Skeletal Muscle Physiology
- Respiratory Disease Research
Background:
- Patients with Chronic Obstructive Pulmonary Disease (COPD) often exhibit locomotory skeletal muscle contractile dysfunction.
- The precise causes of this dysfunction, whether disease-related or due to confounding factors, require clarification.
Purpose of the Study:
- To investigate the impact of emphysema on skeletal muscle function in an animal model.
- Specifically, to determine if emphysema affects force production, fatigability, and recovery speed of locomotory muscles.
Main Methods:
- Utilized a Syrian Golden hamster model with induced emphysema via elastase instillation.
- Measured in situ mechanical properties of the gastrocnemius muscle 8 months post-instillation.
- Compared emphysematous hamsters (n=7) with saline-treated controls (n=5).
Main Results:
- Emphysema significantly increased excised lung volume by 80% (P < 0.01).
- Gastrocnemius muscle in emphysematous hamsters showed increased fatigability (55% reduction vs. 25% in controls, P < 0.05).
- Emphysema impaired muscle recovery, with significantly longer half-times (92s vs. 7s, P < 0.05), but did not affect maximal force or force-velocity characteristics.
Conclusions:
- Emphysema independently increases skeletal muscle fatigability and slows recovery speed.
- These contractile dysfunctions in locomotory muscles may be a key factor contributing to exercise intolerance observed in COPD patients.